Skip to main content

Table 1 Characteristics of the CARLA study population

From: Advanced glycation end products and their ratio to soluble receptor are associated with limitations in physical functioning only in women: results from the CARLA cohort

  Men (n = 967) Women (n = 812)
Age, mean ± SD (years) 65 ± 10.23 64 ± 9.94
<  65 years, N (%) 487 (50.36) 455 (56.03)
> = 65 years, N (%) 480 (49.64) 357 (43.97)
BMI, mean ± SD, (kg/m2) 28.15 ± 4.08 28.54 ± 5.36
Smoker, N, yes (%) 225 (23.27) 119 (14.66)
Food indexa, mean ± SD 14.52 ± 3.20 16.44 ± 3.16
Diabetes mellitus, N (%) 154 (15.93) 120 (14.78)
Cardiovascular disease, N (%) 153 (15.82) 48 (5.91)
Osteoporosis, N (%) 64 (6.62) 142 (17.49)
Creatinine clearance, median (P25/P75) (ml/min) 97.22 (76.61/119.41) 88.95 (71.76/109.86)
AGE-levels, median (P25/P75) (relative units) 12,289 (9548/14796) 11,385 (8574/13712)
sRAGE-levels, median (P25/P75) (pg/ml) 827.62 (604.41/1107.88) 964.49 (706.93/1279.58)
AGE/sRAGE, median (P25/P75) 14.46 (10.01/21.09) 11.38 (8.19/16.37)
Limitations in moderate activities, N (%)
 Severe limitation 61 (6.31) 78 (9.61)
 Minor limitation 246 (25.44) 305 (37.56)
 No limitation 660 (68.25) 429 (52.83)
Limitations in climbing stairs, N (%)
 Severe limitation 69 (7.14) 90 (11.08)
 Minor limitation 361 (37.33) 385 (47.41)
 No limitation 537 (55.53) 337 (41.50)
  1. Note. CRP High sensitive C-reactive protein, BMI Body Mass Index, AGEs Advanced glycation end products, sRAGE Soluble receptor of AGEs, SD Standard deviation, P25/P75 25th/75th percentile
  2. ascore 0–30, high score indicates healthier nutrition
\